You have read all your free articles, to continue reading subscribe to read the rest of this content.
The startup company has completed a heavily oversubscribed fundraise. The new funds will be used initially to expand the company’s clinical trial program for its Dermalyser AI-driven support tool in Sweden and other key European markets, as well as finalize CE marking and commercialization, stAlready a subscriber Login You have read…
The Umeåbased startup company has been granted 2.2 million EUR from EU Horizon 2020, the EU framework program for research and development. The grant will go to Lipum’s ongoing development of a biological pharmaceutical for treatment of chronic inflammatory diseases, reports the company inAlready a subscriber Login You have read all your…
Devyser Diagnostics has announced the completion of a private placement of 7,465 shares, corresponding to SEK 130 million before issuance costs, to Swedbank Robur and the Fourth Swedish National Pension Fund (AP4). The purpose of the issue is primarily to finance the company’s global marketing Already a subscriber Login You…
The NLSDays Super Session about "What's hot in the eyes of international investors?" brought up the importance about having solid science, new and innovative technology and being able to explain this. Alison Hilton from the DNM emphasized the importance of proving yourself from a health economic Already a subscriber Login…
